Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | HTR3A | P46098 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3205113 | 0.98 | KMT2A (0.43) | KMT2AMEN1POLBCYP2D6LMNA | |
| Benzene SCHEMBL28869400 | 0.93 | CYP1A2 (0.42) | KMT2AMEN1POLBCYP2D6LMNA | |
| SCHEMBL8359067 | 0.87 | MEN1 (0.48) | KMT2AMEN1POLBCYP2D6LMNA | |
| SCHEMBL4184984 | 0.86 | MEN1 (0.38) | KMT2AMEN1POLBALDH1A1CHRM2 | |
| SCHEMBL5536887 | 0.84 | ALDH1A1 (0.40) | KMT2AMEN1POLBCYP2D6MAOA | |
| SCHEMBL64132 | 0.84 | SLC29A1 (0.33) | — | |
| SCHEMBL5537405 | 0.82 | ALDH1A1 (0.42) | KMT2AMEN1CYP2D6MAOAALDH1A1 | |
| SCHEMBL5547138 | 0.82 | ALDH1A1 (0.42) | KMT2AMEN1CYP2D6MAOAALDH1A1 | |
| SCHEMBL5546034 | 0.82 | ALDH1A1 (0.42) | KMT2AMEN1CYP2D6MAOAALDH1A1 | |
| SCHEMBL5536866 | 0.82 | ALDH1A1 (0.42) | KMT2AMEN1CYP2D6MAOAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120165474-A1 | POLYFARNESENES | Amyris, Inc. (US) | 2012-06-28 | — | — | US | claimed |
| EP-2346832-A1 | TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS | Glaxo Group Limited (GB) | 2011-07-27 | — | — | EP | claimed |
| EP-1278735-B1 | 2,4-DI(HETERO-)ARYLAMINO(-OXY)-5-SUBSTITUTED PYRIMIDINES AS ANTINEOPLASTIC AGENTS | ASTRAZENECA AB (SE) | 2010-06-30 | — | — | EP | claimed |
| WO-2010049366-A1 | TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS | GLAXO GROUP LIMITED (GB) | 2010-05-06 | — | — | WO | claimed |
| US-7067522-B2 | 2,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents | ASTRAZENECA AB (SE) | 2006-06-27 | — | — | US | claimed |
| EP-1575947-A1 | 2-OXOPYRIDIN-3-YL THIA(DI)AZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES | Amgen Inc. (US) | 2005-09-21 | — | — | EP | claimed |
| US-20050090515-A1 | 2,4,DI (hetero-) arylamino (-oxy) -5-substituted pyrimidines as antineoplastic agents | ASTRAZENECA AB | 2005-04-28 | — | — | US | claimed |
| US-6838464-B2 | 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agents | ASTRAZENECA AB (SE) | 2005-01-04 | — | — | US | claimed |
| US-20040147561-A1 | Pyrid-2-one derivatives and methods of use | SYNGENTA CROP PROTECTION AG (CH) | 2004-07-29 | — | — | US | claimed |
| WO-2004060890-A1 | 2-OXOPYRIDIN-3-YL THIA (DI) AZOLE DERIVATES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES | AMGEN INC. (US) | 2004-07-22 | — | — | WO | claimed |
| US-20030181474-A1 | 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents | ASTRAZENECA AB (SE) | 2003-09-25 | — | — | US | claimed |
| EP-1278735-A1 | 2,4-DI(HETERO-)ARYLAMINO(-OXY)-5-SUBSTITUTED PYRIMIDINES AS ANTINEOPLASTIC AGENTS | AstraZeneca AB (SE) | 2003-01-29 | — | — | EP | claimed |
| WO-2001064656-A1 | 2,4,DI(HETERO-)ARYLAMINO(-OXY)-5-SUBSTITUTED PYRIMIDINES AS ANTINEOPLASTIC AGENTS | ASTRAZENECA AB (SE) | 2001-09-07 | — | — | WO | claimed |
| EP-0173933-B1 | 1,6-NAPHTHYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENT CONTAINING THEM | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1989-11-29 | — | — | EP | claimed |
| US-4525478-A | Certain 4-aryl-1,4-dihydro-3,5-pyridinedicarboxylates having vasodilating and anti-hypertensive properties | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1985-06-25 | — | — | US | claimed |
| US-4370334-A | VASODILATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-01-25 | — | — | US | claimed |
| US-4338322-A | 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-07-06 | — | — | US | claimed |
| US-4284634-A | HYPOTENSIVE VASODILATORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-08-18 | — | — | US | claimed |
| US-4159330-A | ANTIALLERGENS | CARLO ERBA S.P.A. (IT) | 1979-06-26 | — | — | US | claimed |
| US-20230130980-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | TECHFIELDS PHARMA CO., LTD. (CN) | 2023-04-27 | — | — | US | disclosed |
| US-11485744-B2 | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds | TECHFIELDS PHARMA CO., LTD. (CN) | 2022-11-01 | — | — | US | disclosed |
| US-20210206782-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | TECHFIELDS PHARMA CO., LTD. (CN) | 2021-07-08 | — | — | US | disclosed |
| US-10233197-B2 | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds | TECHFIELDS PHARMA CO., LTD. (CN) | 2019-03-19 | — | — | US | disclosed |
| US-20180222921-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | PREMIER RESEARCH INTERNATIONAL, LLC | 2018-08-09 | — | — | US | disclosed |
| US-9969751-B2 | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds | TECHFIELDS PHARMA CO., LTD. (CN) | 2018-05-15 | — | — | US | disclosed |
| EP-2817342-B1 | POLYMERIZATION OF COMPOSITIONS COMPRISING A FARNESENE | AMYRIS INC (US) | 2016-05-25 | — | — | EP | disclosed |
| US-20150025193-A1 | POLYMERIZATION OF COMPOSITIONS COMPRISING A FARNESENE | Amyris, Inc. (US) | 2015-01-22 | — | — | US | disclosed |
| EP-2817342-A1 | POLYMERIZATION OF COMPOSITIONS COMPRISING A FARNESENE | Amyris, Inc. (US) | 2014-12-31 | — | — | EP | disclosed |
| EP-1974914-B1 | Method of preparing lithographic printing plate | FUJIFILM CORP (JP) | 2014-02-26 | — | — | EP | disclosed |
| US-8592543-B2 | Polyfarnesenes | EUAGORE, LLC | 2013-11-26 | — | — | US | disclosed |
| WO-2013126129-A1 | POLYMERIZATION OF COMPOSITIONS COMPRISING A FARNESENE | Amyris, Inc. (US) | 2013-08-29 | — | — | WO | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| US-20130018029-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | TECHFIELDS PHARMA CO., LTD (CN) | 2013-01-17 | — | — | US | disclosed |
| EP-1555267-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES | OTSUKA PHARMA CO LTD (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-20120165474-A1 | POLYFARNESENES | Amyris, Inc. (US) | 2012-06-28 | — | — | US | disclosed |
| US-20120157371-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | PREMIER RESEARCH INTERNATIONAL, LLC | 2012-06-21 | — | — | US | disclosed |
| US-20120070399-A1 | ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD | L'OREAL (FR) | 2012-03-22 | — | — | US | disclosed |
| US-20110263588-A1 | TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS | GLAXO GROUP LIMITED (GB) | 2011-10-27 | — | — | US | disclosed |
| EP-2346832-A1 | TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS | Glaxo Group Limited (GB) | 2011-07-27 | — | — | EP | disclosed |
| US-20100231670-A1 | SET FOR INK JET RECORDING, AND INK JET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2010-09-16 | — | — | US | disclosed |
| EP-1278735-B1 | 2,4-DI(HETERO-)ARYLAMINO(-OXY)-5-SUBSTITUTED PYRIMIDINES AS ANTINEOPLASTIC AGENTS | ASTRAZENECA AB (SE) | 2010-06-30 | — | — | EP | disclosed |
| WO-2010049366-A1 | TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS | GLAXO GROUP LIMITED (GB) | 2010-05-06 | — | — | WO | disclosed |
| US-20100080908-A1 | INK SET AND METHOD FOR FORMING IMAGE | FUJIFILM CORPORATION (JP) | 2010-04-01 | — | — | US | disclosed |
| EP-2169017-A1 | Ink set and method for forming image | Fujifilm Corporation (JP) | 2010-03-31 | — | — | EP | disclosed |
| US-20100040548-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | TECHFIELDS PHARMA CO., LTD (CN) | 2010-02-18 | — | — | US | disclosed |
| US-20090246422-A1 | INKJET RECORDING MEDIUM AND METHOD FOR MANUFACTURING THE SAME | FUJIFILM CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
| US-20090221458-A1 | SUCCINIC ACID SEMI-AMIDES AS ANTI-CORROSIVE AGENTS | CAMENZIND HUGO | 2009-09-03 | — | — | US | disclosed |
| US-20090214805-A1 | INKJET RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090043081-A1 | INK JET RECORDING SET AND INK JET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2009-02-12 | — | — | US | disclosed |
| EP-2004412-A1 | INK JET RECORDING SET AND INK JET RECORDING METHOD | FUJIFILM Corporation (JP) | 2008-12-24 | — | — | EP | disclosed |
| EP-1979173-A1 | SET FOR INK JET RECORDING, AND INK JET RECORDING METHOD | FUJIFILM Corporation (JP) | 2008-10-15 | — | — | EP | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| WO-2007088794-A1 | INK JET RECORDING SET AND INK JET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2007-08-09 | — | — | WO | disclosed |
| WO-2007088724-A1 | SET FOR INK JET RECORDING, AND INK JET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2007-08-09 | — | — | WO | disclosed |
| WO-2007037134-A9 | INKJET RECORDING MEDIUM AND METHOD FOR MANUFACTURING THE SAME | FUJIFILM CORP (JP) | 2007-05-24 | — | — | WO | disclosed |
| US-20060241151-A1 | Pyrid-2-one derivatives and methods of use | AMGEN, INC. (US) | 2006-10-26 | — | — | US | disclosed |
| WO-2006086609-A2 | INHIBITORS OF TRYPTASE | AXYS PHARMACEUTICALS, INC. (US) | 2006-08-17 | — | — | WO | disclosed |
| US-7067522-B2 | 2,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents | ASTRAZENECA AB (SE) | 2006-06-27 | — | — | US | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| US-20050267003-A1 | Succinic acid semi-amides as anti-corrosives agents | CIBA SPECIALTY CHEMICALS CORP. | 2005-12-01 | — | — | US | disclosed |
| EP-1575947-A1 | 2-OXOPYRIDIN-3-YL THIA(DI)AZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES | Amgen Inc. (US) | 2005-09-21 | — | — | EP | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| EP-0889097-B1 | PHTHALOCYANINE COMPOUNDS, PROCESS FOR PREPARING THE SAME, AND OPTICAL RECORDING MEDIUM MADE USING THE SAME | NIPPON CATALYTIC CHEM IND (JP) | 2005-06-29 | — | — | EP | disclosed |
| EP-1539677-A2 | SUCCINIC ACID SEMI-AMIDES AS ANTI-CORROSIVES AGENTS | Ciba SC Holding AG (CH) | 2005-06-15 | — | — | EP | disclosed |
| US-20050090515-A1 | 2,4,DI (hetero-) arylamino (-oxy) -5-substituted pyrimidines as antineoplastic agents | ASTRAZENECA AB | 2005-04-28 | — | — | US | disclosed |
| US-6838464-B2 | 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agents | ASTRAZENECA AB (SE) | 2005-01-04 | — | — | US | disclosed |
| US-20040147561-A1 | Pyrid-2-one derivatives and methods of use | SYNGENTA CROP PROTECTION AG (CH) | 2004-07-29 | — | — | US | disclosed |
| WO-2004060890-A1 | 2-OXOPYRIDIN-3-YL THIA (DI) AZOLE DERIVATES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES | AMGEN INC. (US) | 2004-07-22 | — | — | WO | disclosed |
| US-20040077709-A1 | Neuronal death inhibitors | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-04-22 | — | — | US | disclosed |
| WO-2004026811-A2 | SUCCINIC ACID SEMI-AMIDES AS ANTI-CORROSIVES AGENTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-04-01 | — | — | WO | disclosed |
| EP-1027351-B1 | PHENANTHROLINE DERIVATIVES | FIBROGEN INC (US) | 2003-12-03 | — | — | EP | disclosed |
| US-20030181474-A1 | 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents | ASTRAZENECA AB (SE) | 2003-09-25 | — | — | US | disclosed |
| EP-1278735-A1 | 2,4-DI(HETERO-)ARYLAMINO(-OXY)-5-SUBSTITUTED PYRIMIDINES AS ANTINEOPLASTIC AGENTS | AstraZeneca AB (SE) | 2003-01-29 | — | — | EP | disclosed |
| US-6417220-B2 | A MEDICINE FOR PREVENTIVE/TREATMENT OF DISEASE CAUSED BY MITOCHONDRIAL MEMBRANE DEPOLARIZATION BECAUSE OF ELEVATION OF INTRACELLULAR CALCIUM ION CONCENTRATION; BENZODIAZEPINE RECEPTOR ANTAGONIST, E.G.,NEFIRACETAM; ANTIISCHEMIC AGENTS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2002-07-09 | — | — | US | disclosed |
| EP-1180366-A9 | NEURONAL DEATH INHIBITORS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2002-04-24 | — | — | EP | disclosed |
| EP-1180366-A1 | NEURONAL DEATH INHIBITORS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2002-02-20 | — | — | EP | disclosed |
| US-20010051641-A1 | MITOCHONDRIAL MEMBRANE STABILIZER | DAIICHI PHARMACEUTICAL CO., LTD (JP) | 2001-12-13 | — | — | US | disclosed |
| WO-2001064656-A1 | 2,4,DI(HETERO-)ARYLAMINO(-OXY)-5-SUBSTITUTED PYRIMIDINES AS ANTINEOPLASTIC AGENTS | ASTRAZENECA AB (SE) | 2001-09-07 | — | — | WO | disclosed |
| US-20010001101-A1 | Phenanthroline derivatives | ZENECA LIMITED | 2001-05-10 | — | — | US | disclosed |
| US-6200974-B1 | FOR PRODUCING AN ANTI-FIBROPROLIFERATIVE EFFECT | ZENECA LIMITED (GB) | 2001-03-13 | — | — | US | disclosed |
| EP-1027351-A1 | PHENANTHROLINE DERIVATIVES | FIBROGEN, INC. (US) | 2000-08-16 | — | — | EP | disclosed |
| EP-1022029-A1 | NOOTROPIC AGENT | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2000-07-26 | — | — | EP | disclosed |
| US-5998609-A | OPTICAL RECORDING MEDIA | NIPPON SHOKUBAI CO., LTD. (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0953356-A1 | MITOCHONDRIAL MEMBRANE STABILIZER | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1999-11-03 | — | — | EP | disclosed |
| US-5916898-A | ANTIFIBROPROLIFERTIVE, ENZYME INHIBITORS OF PYROLYL 4-HYDROXYLASE, ANTIARTHRITIC AGENTS | ZENECA LIMITED (GB) | 1999-06-29 | — | — | US | disclosed |
| WO-1999021860-A1 | PHENANTHROLINE DERIVATIVES | FIBROGEN, INC. (US) | 1999-05-06 | — | — | WO | disclosed |
| EP-0889097-A1 | PHTHALOCYANINE COMPOUNDS, PROCESS FOR PREPARING THE SAME, AND OPTICAL RECORDING MEDIUM MADE USING THE SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 1999-01-07 | — | — | EP | disclosed |
| EP-0413314-B1 | Silver halide photographic material | FUJI PHOTO FILM CO LTD (JP) | 1997-03-26 | — | — | EP | disclosed |
| US-5354892-A | Treating cardiovascular disorders; endopeptidase inhibitors; diuretics | CIBA-GEIGY CORPORATION (US) | 1994-10-11 | — | — | US | disclosed |
| US-5217996-A | Endopeptidase inhibitors | CIBA-GEIGY CORPORATION (US) | 1993-06-08 | — | — | US | disclosed |
| US-5213952-A | Improved color reproducibility | FUJI PHOTO FILM CO., LTD. (JP) | 1993-05-25 | — | — | US | disclosed |
| US-5108888-A | Compound to reduce residual staining | FUJI PHOTO FILM CO., LTD. (JP) | 1992-04-28 | — | — | US | disclosed |
| US-5032606-A | Novel fluorinated resorcinol ethers and their use as anti-allergics and anti-inflammatories | CIBA-GEIGY CORPORATION (US) | 1991-07-16 | — | — | US | disclosed |
| EP-0413314-A1 | Silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1991-02-20 | — | — | EP | disclosed |
| EP-0099329-B1 | DITHIO COMPOUNDS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE | Zyma SA (CH) | 1990-10-31 | — | — | EP | disclosed |
| US-4946861-A | TREATMENT OF LIVER DISORDERS | ZYMA SA (CH) | 1990-08-07 | — | — | US | disclosed |
| US-4906553-A | Processing process for silver halide black and white photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1990-03-06 | — | — | US | disclosed |
| EP-0341637-A2 | Processing process for silver halide black and white photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1989-11-15 | — | — | EP | disclosed |
| EP-0222961-B1 | RESORCINOL ETHERS | CIBA-GEIGY AG (CH) | 1989-09-20 | — | — | EP | disclosed |
| US-4863942-A | Novel resorcinol ethers and anti-inflammatory and anti-allergic use thereof | CIBA-GEIGY CORPORATION (US) | 1989-09-05 | — | — | US | disclosed |
| US-4855289-A | Combination of two active substances | WESTER PER O (SE) | 1989-08-08 | — | — | US | disclosed |
| US-4853393-A | HYPOTENSIVE AGENTS, ANTICOAGULANTS | CIBA-GEIGY CORPORATION (US) | 1989-08-01 | — | — | US | disclosed |
| US-4820726-A | Oxaloamino substituted fluorinated resorcinol ethers and anti-allergic and anti-inflammatory use thereof | CIBA-GEIGY CORPORATION (US) | 1989-04-11 | — | — | US | disclosed |
| US-4818765-A | TREATING LIVER, RESPIRATORY TRACT, VASCULAR DISORDERS | CIBA-GEIGY CORPORATION (US) | 1989-04-04 | — | — | US | disclosed |
| US-4808603-A | HYPOTENSIVE, VASODILATION AGENTS | CIBA-GEIGY CORPORATION (US) | 1989-02-28 | — | — | US | disclosed |
| US-4735959-A | HYPOGLYCEMIC AGENTS | DR. KARL THOMAE GMBH (DE) | 1988-04-05 | — | — | US | disclosed |
| US-4670604-A | Novel fluorinated resorcinol ethers | CIBA-GEIGY CORPORATION (US) | 1987-06-02 | — | — | US | disclosed |
| EP-0222961-A1 | Resorcinol ethers | CIBA-GEIGY AG (CH) | 1987-05-27 | — | — | EP | disclosed |
| US-4646309-A | EMISSION AT A SPECIFIC WAVELENGTH | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JP) | 1987-02-24 | — | — | US | disclosed |
| US-4616002-A | HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1986-10-07 | — | — | US | disclosed |
| EP-0165897-A2 | Resorcin ethers | CIBA-GEIGY AG (CH) | 1985-12-27 | — | — | EP | disclosed |
| US-4497808-A | N-Oxide compounds useful in the treatment of cardiovascular ailments | CIBA-GEIGY CORPORATION (US) | 1985-02-05 | — | — | US | disclosed |
| US-4476132-A | Acylquinolinone derivatives, and antiallergic preparations and methods of inhibiting allergic reactions using them | CIBA-GEIGY CORPORATION (US) | 1984-10-09 | — | — | US | disclosed |
| US-4453252-A | A PYRAZOLOAZAXANTHENOISOQUINOLINONE DYE | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1984-06-05 | — | — | US | disclosed |
| EP-0099329-A1 | Dithio compounds, pharmaceutical preparations containing them and their use | Zyma SA (CH) | 1984-01-25 | — | — | EP | disclosed |
| US-4341790-A | CEREBRAL CIRCULATORY, ATROPHY, AND AGING | A. NATTERMANN & CIE. GMBH (DE) | 1982-07-27 | — | — | US | disclosed |
| US-4323363-A | DISPERSE DYE USED ON POLYESTERS MIXED WITH CELLULOSE | CASSELLA AKTIENGESELLSCHAFT (DE) | 1982-04-06 | — | — | US | disclosed |
| US-4303673-A | N-Propionylsarcosineanilides, process for their preparation, and pharmaceutical compositions containing them | A. NATTERMANN & CIE. GMBH (DE) | 1981-12-01 | — | — | US | disclosed |
| US-4297358-A | AS ANTIALLERGENS | CIBA-GEIGY CORPORATION (US) | 1981-10-27 | — | — | US | disclosed |
| US-4268671-A | PERINONE DYES USED FOR DYEING POLYESTERS | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) | 1981-05-19 | — | — | US | disclosed |
| US-4214094-A | ANTILIPEMIC AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-07-22 | — | — | US | disclosed |
| US-4159330-A | ANTIALLERGENS | CARLO ERBA S.P.A. (IT) | 1979-06-26 | — | — | US | disclosed |
| US-4152189-A | Method of utilizing polyacrylic hot-melt adhesives | ROHM AND HAAS COMPANY (US) | 1979-05-01 | — | — | US | disclosed |
| US-4147850-A | ACRYLATE, UNSATURATED AMINE OR ACID, WATER | ROHM AND HAAS COMPANY (US) | 1979-04-03 | — | — | US | disclosed |
| US-4065523-A | COPOLYMERIZATION | ROHM AND HAAS COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
| US-4045517-A | Polyacrylic hot melt adhesives | ROHM AND HAAS COMPANY (US) | 1977-08-30 | — | — | US | disclosed |
| US-4045517-A | Polyacrylic hot melt adhesives | ROHM AND HAAS COMPANY (US) | 1977-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (18 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263588-A1 | TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS | GRM5, GRM1, GRM3 | KMT2A 1449/4885MEN1 4701/4885POLB 4360/4885 |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | KMT2A 4267/4885MEN1 3295/4885POLB 1637/4885 |
| US-20180222921-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | SLC7A1, VIP, HPGDS | KMT2A 4651/4885MEN1 2986/4885POLB 1882/4885 |
| US-20210206782-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | SLC7A1, VIP, HAMP | KMT2A 4620/4885MEN1 3194/4885POLB 1766/4885 |
| US-11485744-B2 | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds | SLC7A1, VIP, HPGDS | KMT2A 4651/4885MEN1 2986/4885POLB 1882/4885 |
| US-20230130980-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | SLC7A1, VIP, HPGDS | KMT2A 4651/4885MEN1 2986/4885POLB 1882/4885 |
| US-20130018029-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | SLC7A1, VIP, HAMP | KMT2A 4620/4885MEN1 3194/4885POLB 1766/4885 |
| US-20120070399-A1 | ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD | EGFR, ERCC1, ERCC5 | KMT2A 4041/4885MEN1 778/4885POLB 204/4885 |
| US-20040147561-A1 | Pyrid-2-one derivatives and methods of use | PLPBP, PNPO, PDXK | KMT2A 3617/4885MEN1 1687/4885POLB 912/4885 |
| US-20040077709-A1 | Neuronal death inhibitors | CASP3, CASP1, AIFM1 | KMT2A 2295/4885MEN1 4266/4885POLB 3704/4885 |
| US-20030181474-A1 | 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents | CDK2, CCNI, CDK1 | KMT2A 909/4885MEN1 3683/4885POLB 254/4885 |
| US-10233197-B2 | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds | SLC7A1, VIP, HAMP | KMT2A 4620/4885MEN1 3194/4885POLB 1766/4885 |
| US-20100040548-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | SLC7A1, VIP, HAMP | KMT2A 4620/4885MEN1 3194/4885POLB 1766/4885 |
| US-20060241151-A1 | Pyrid-2-one derivatives and methods of use | PLPBP, PNPO, PDXK | KMT2A 3504/4885MEN1 1639/4885POLB 896/4885 |
| US-20010051641-A1 | MITOCHONDRIAL MEMBRANE STABILIZER | TFAM, MDH2, NLN | KMT2A 1409/4885MEN1 3863/4885POLB 1539/4885 |
| US-20050090515-A1 | 2,4,DI (hetero-) arylamino (-oxy) -5-substituted pyrimidines as antineoplastic agents | CDK2, CDK4, CCNI | KMT2A 862/4885MEN1 4075/4885POLB 299/4885 |
| US-20010001101-A1 | Phenanthroline derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, COL1A1, COL2A1 | KMT2A 1250/4885MEN1 2187/4885POLB 2515/4885 |
| US-20120157371-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | SLC7A1, VIP, HPGDS | KMT2A 4651/4885MEN1 2986/4885POLB 1882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.